AGM/EGMJun 2, 2026, 04:26 PM
VolitionRx Announces 2026 Annual Meeting Agenda, Share Reduction Proposal
AI Summary
VolitionRx Limited has filed its Definitive Proxy Statement (DEF 14A) for its 2026 Annual Meeting of Stockholders, scheduled for July 17, 2026. The meeting agenda includes the election of directors, ratification of its independent registered public accounting firm, an advisory vote on executive compensation, a proposal to reduce authorized shares from 325,000,000 to 150,000,000, and the approval of the 2026 Stock Incentive Plan. The company also disclosed that a one-for-twenty reverse stock split was effected on April 28, 2026, and provided details on significant shareholdings, including Lagoda Investment Management, L.P. (9.8%) and Lind Global Asset Management XII LLC (4.99%).
Key Highlights
- VolitionRx Limited announces its 2026 Annual Meeting of Stockholders to be held on July 17, 2026.
- Key proposals include election of seven directors, ratification of independent auditors, advisory vote on executive compensation, reduction of authorized shares, and approval of the 2026 Stock Incentive Plan.
- The company implemented a one-for-twenty reverse stock split effective April 28, 2026.
- Record date for determining stockholders entitled to vote is May 26, 2026.
- Lagoda Investment Management, L.P. beneficially owns 9.8% of outstanding shares.
- Lind Global Asset Management XII LLC beneficially owns 4.99% of outstanding shares, subject to limitations.
Price Impact
More from VNRX